CellaraRx Therapeutics Website
1 known investors
CellaraRx analyzes tumor biology at the single-cell level to predict whether a patient is likely to respond to a cancer treatment before clinical trial enrollment. It serves drug developers, pharma investors, and clinicians by identifying treatment-resistant cells and improving patient selection for oncology drug trials.
AI & Machine LearningBiotechHealthtech